Cargando…
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges
A quantitative deficiency of normally functioning insulin-producing pancreatic beta cells is a major contributor to all common forms of diabetes. This is the underlying premise for attempts to replace beta cells in people with diabetes by pancreas transplantation, pancreatic islet transplantation, a...
Autores principales: | Wang, Peng, Karakose, Esra, Choleva, Lauryn, Kumar, Kunal, DeVita, Robert J., Garcia-Ocaña, Adolfo, Stewart, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322843/ https://www.ncbi.nlm.nih.gov/pubmed/34335466 http://dx.doi.org/10.3389/fendo.2021.671946 |
Ejemplares similares
-
Grand Challenge in Adrenal Endocrinology: Is the Legacy of the Past a Challenge for the Future of Precision Medicine?
por: Chiodini, Iacopo, et al.
Publicado: (2021) -
Parathyroid Imaging: Past, Present, and Future
por: Morris, Michael A., et al.
Publicado: (2022) -
Classification of diabetic retinopathy: Past, present and future
por: Yang, Zhengwei, et al.
Publicado: (2022) -
Achievements of the past and Hopes for the Future
Publicado: (1921) -
IGF-IR Targeted Therapy: Past, Present and Future
por: Janssen, Joseph A. M. J. L., et al.
Publicado: (2014)